CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Press Releases Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 21:00:02 10/04/2026 BST			5-day change	1st Jan Change
175.65 ^USD	+0.06%		+1.01%	-11.95%

04-08	Baird Raises Price Target on Charles River Laboratories International to $200 From $197, Maintains Outperform Rating	MT
03-31	AI-led selloff in contract research firms may be misjudging disruption risk	RE

Press Releases

04-09	Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association	BU
04-06	NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX	PR
03-02	Charles River Laboratories to Present at TD Cowen and Barclays Conferences	BU
02-25	Charles River Laboratories Provides Update on Planned Divestitures	BU
02-18	Charles River Laboratories International : Q4 2025 Earnings Presentation	PU
02-18	Charles River: Q4 Earnings Snapshot	AQ
02-18	Charles River Laboratories Announces Executive Appointments	BU
02-18	Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance	BU
01-21	Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call	BU
01-21	Charles River Enters Manufacturing Collaboration with Gazi University	BU
01-20	Charles River Laboratories Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL	PR
01-13	Charles River Laboratories International : at the J.P. Morgan 44th Annual Healthcare Conference Presentation	PU
01-12	Charles River Laboratories Provides Business Updates	BU
01-08	Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan	BU
12-11	Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort	BU
12-01	HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS	PR
12-01	Charles River Laboratories to Present at Evercore Healthcare Conference	BU
11-24	Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL	BU
11-17	Charles River Laboratories to Present at Jefferies Global Healthcare Conference	BU
11-08	Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL	PR
11-05	Charles River Laboratories International : Q3 2025 Earnings Presentation	PU
11-05	Charles River: Q3 Earnings Snapshot	AQ
11-05	Charles River Laboratories Announces Third-Quarter 2025 Results	BU
11-05	Charles River Laboratories Provides Update on Strategic Review	BU
27/10/25	Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL	BU